166 related articles for article (PubMed ID: 12948023)
1. Interaction of differently designed immunoliposomes with colon cancer cells and Kupffer cells. An in vitro comparison.
Koning GA; Morselt HW; Gorter A; Allen TM; Zalipsky S; Scherphof GL; Kamps JA
Pharm Res; 2003 Aug; 20(8):1249-57. PubMed ID: 12948023
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of differently designed immunoliposome formulations in rats with or without hepatic colon cancer metastases.
Koning GA; Morselt HW; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
Pharm Res; 2001 Sep; 18(9):1291-8. PubMed ID: 11683242
[TBL] [Abstract][Full Text] [Related]
3. Interference of macrophages with immunotargeting of liposomes.
Koning GA; Kamps JA; Scherphof GL
J Liposome Res; 2002; 12(1-2):107-19. PubMed ID: 12604044
[TBL] [Abstract][Full Text] [Related]
4. Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells.
Koning GA; Morselt HW; Velinova MJ; Donga J; Gorter A; Allen TM; Zalipsky S; Kamps JA; Scherphof GL
Biochim Biophys Acta; 1999 Aug; 1420(1-2):153-67. PubMed ID: 10446299
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake.
Moghimi M; Moghimi SM
J Drug Target; 2008 Aug; 16(7):586-90. PubMed ID: 18686128
[TBL] [Abstract][Full Text] [Related]
6. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.
Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M
Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861
[TBL] [Abstract][Full Text] [Related]
7. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer.
Kamps JA; Koning GA; Velinova MJ; Morselt HW; Wilkens M; Gorter A; Donga J; Scherphof GL
J Drug Target; 2000; 8(4):235-45. PubMed ID: 11144234
[TBL] [Abstract][Full Text] [Related]
8. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals].
Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS
Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866
[TBL] [Abstract][Full Text] [Related]
9. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures.
Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM
Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618
[TBL] [Abstract][Full Text] [Related]
10. Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro.
Derksen JT; Morselt HW; Kalicharan D; Hulstaert CE; Scherphof GL
Exp Cell Res; 1987 Jan; 168(1):105-15. PubMed ID: 3023116
[TBL] [Abstract][Full Text] [Related]
11. Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by kupffer cells in vitro 1 *.
Koning GA; Morselt HW; Kamps JA; Scherphof GL
J Liposome Res; 2001; 11(2-3):195-209. PubMed ID: 19530933
[TBL] [Abstract][Full Text] [Related]
12. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
Huwyler J; Yang J; Pardridge WM
J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
[TBL] [Abstract][Full Text] [Related]
13. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
Koning GA; Kamps JA; Scherphof GL
Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
[TBL] [Abstract][Full Text] [Related]
14. PEG-immunoliposome.
Maruyama K
Biosci Rep; 2002 Apr; 22(2):251-66. PubMed ID: 12428903
[TBL] [Abstract][Full Text] [Related]
15. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
16. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
Nam SM; Kim HS; Ahn WS; Park YS
Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s.
Shimada K; Kamps JA; Regts J; Ikeda K; Shiozawa T; Hirota S; Scherphof GL
Biochim Biophys Acta; 1997 Jun; 1326(2):329-41. PubMed ID: 9218563
[TBL] [Abstract][Full Text] [Related]
18. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro targeting of sterically stabilized liposomes modified with chimeric TNT-3 monoclonal antibody.
Pan H; Niu GQ; Pan J; Lu WY
Yao Xue Xue Bao; 2006 Jun; 41(6):506-12. PubMed ID: 16927823
[TBL] [Abstract][Full Text] [Related]
20. Lipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama K; Kennel SJ; Huang L
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
